Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li, Allen Yujie Jiang, Idris Raji, et al.
Nature Biomedical Engineering (2023)
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry
Bowen Li, Idris O. Raji, Akiva G. R. Gordon, et al.
Nature Materials (2024) Vol. 23, Iss. 7, pp. 1002-1008
Closed Access | Times Cited: 32
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
Mariona Estapé Sentí, Lucía García del Valle, Raymond M. Schiffelers
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115190-115190
Open Access | Times Cited: 19
Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy
Shufen Xu, Yue Xu, Nicholas C. Solek, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 19
Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
Yisi Tang, Bao Liu, Yuting Zhang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115304-115304
Closed Access | Times Cited: 17
AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery
Yue Xu, Shihao Ma, Haotian Cui, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Rational design of ICD-inducing nanoparticles for cancer immunotherapy
Zhanzhan Zhang, Zheng Pan, Qiushi Li, et al.
Science Advances (2024) Vol. 10, Iss. 6
Open Access | Times Cited: 14
Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 21
Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length
Kaitlin Mrksich, Marshall S. Padilla, Ryann A. Joseph, et al.
Journal of Biomedical Materials Research Part A (2024) Vol. 112, Iss. 9, pp. 1494-1505
Open Access | Times Cited: 12
Engineering LNPs with polysarcosine lipids for mRNA delivery
Diana D. Kang, Xucheng Hou, Leiming Wang, et al.
Bioactive Materials (2024) Vol. 37, pp. 86-93
Open Access | Times Cited: 12
An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
Lin Yang, Xuehua Chen, Ke Wang, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 727-727
Open Access | Times Cited: 11
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10
Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70
Byron Brook, Valérie Duval, Soumik Barman, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 757
Closed Access | Times Cited: 9
A Nanoparticle Vaccine Displaying Conserved Epitopes of the Preexisting Neutralizing Antibody Confers Broad Protection against SARS-CoV-2 Variants
Xuefan Wu, Wei Li, Heng Rong, et al.
ACS Nano (2024) Vol. 18, Iss. 27, pp. 17749-17763
Closed Access | Times Cited: 7
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 7
Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Jialiang Wang, Yaopeng Ding, K. Chul Chong, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1148-1148
Open Access | Times Cited: 7
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7
The potential of mRNA vaccines in cancer nanomedicine and immunotherapy
Shulin Pan, Rangrang Fan, Bo Han, et al.
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 20-31
Closed Access | Times Cited: 17
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 5
Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy
Rocío Celeste Gambaro, Ignacio Rivero Berti, María J. Limeres, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 771-771
Open Access | Times Cited: 5
pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
Po‐Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Closed Access | Times Cited: 5
3D Multispheroid Assembly Strategies towards Tissue Engineering and Disease Modeling
Tong Zhu, Yan Hu, Haitao Cui, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 5
Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
Zhongyan Wu, Weilu Sun, Hailong Qi
Vaccines (2024) Vol. 12, Iss. 8, pp. 873-873
Open Access | Times Cited: 5
Advances and applications of RNA vaccines in tumor treatment
Ruohan Yang, Jiuwei Cui
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top